ACOR

Acorda Therapeutics, Inc. News Headlines

$36.45
*  
0.36
0.98%
Get ACOR Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading ACOR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Acorda Therapeutics To Participate Baird Healthcare Conference; At 10:50 AM ET
9/4/2014 9:50:00 AM - RTT News


Bullish Two Hundred Day Moving Average Cross - ACOR
8/26/2014 3:45:01 PM - BNK Invest


Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog
8/4/2014 8:20:00 AM - Zacks.com


Will Teva Pharmaceutical (TEVA) Beat Q2 Earnings Estimates? - Analyst Blog
7/30/2014 3:02:00 PM - Zacks.com


Healthcare Spending Uptrend: 3 Medical Stocks for Strong Growth - Analyst Blog
7/23/2014 9:28:07 AM - Zacks.com


Markets Edge Higher; Alcoa Profit Beats Street View
7/9/2014 9:20:52 AM - Benzinga


Sector Update: Healthcare Shares Flat Pre-Market; Acorda Could File Patent Infringement Suit
6/26/2014 7:37:44 AM - MT Newswires


Sector Update: Healthcare
6/26/2014 7:37:06 AM - MT Newswires


ACOR Makes Notable Cross Below Critical Moving Average
6/25/2014 3:32:54 PM - BNK Invest


Acorda Therapeutics (ACOR) in Focus: Stock Moves 7.8% Higher - Tale of the Tape
6/19/2014 8:18:00 AM - Zacks.com


Sector Update: Healthcare
6/18/2014 7:55:02 AM - MT Newswires


Acorda Therapeutics (ACOR) in Focus: Stock Tumbles 9% - Tale of the Tape
6/18/2014 7:55:00 AM - Zacks.com


Sector Update: Healthcare Shares Flat Pre-Market; Pfizer Teams with Cellectis on Immunotherapy
6/18/2014 7:51:02 AM - MT Newswires


Mid-Afternoon Market Update: Oil Falls, US Indexes Rise In Afternoon Session
6/17/2014 2:16:38 PM - Benzinga


Mid-Day Market Update: Amira Rises On Upbeat Earnings; Acorda Therapeutics Shares Tumble
6/17/2014 11:41:01 AM - Benzinga


Mid-Morning Market Update: Markets Gain; FactSet Posts Rise In Revenue
6/17/2014 9:27:12 AM - Benzinga


First Week of January 2015 Options Trading For Acorda Therapeutics (ACOR)
5/20/2014 10:59:48 AM - BNK Invest


Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 12:43:01 PM - Zacks.com


Acorda Down on Plumiaz CRL - Analyst Blog
5/5/2014 2:12:01 PM - Zacks.com


Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases
4/23/2014 8:48:00 AM - Seeking Alpha


Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 1:35:00 PM - Seeking Alpha


Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 11:54:00 AM - Seeking Alpha


Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha


Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 10:54:36 AM - SeekingAlpha


From Lab Bench To Bedside: David Lowe Brings Common Sense To Neuroscience Investing
3/30/2014 7:38:00 AM - Seeking Alpha